Gem Pharmaceuticals

Specialty company developing anthracycline derivatives to eliminate cardiotoxicity side effect

placeBirmingham, Alabama, United States calendar_todayFounded 2003 language gempharmaceuticals.com

Innovation

8 patent families (6 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 78 times.

YearFilings
20123
20133
20154
20162
20181
20201
20211
20221

Investor mix

1 investor on record.

Investor typeCountShare
Private equity1100%
Coming soon